Works matching IS 15524949 AND DT 2024 AND VI 106 AND IP 4
Results: 10
Issue highlights—July 2024.
- Published in:
- Cytometry. Part B, 2024, v. 106, n. 4, p. 223, doi. 10.1002/cyto.b.22199
- By:
- Publication type:
- Article
Comparison of three machine learning algorithms for classification of B‐cell neoplasms using clinical flow cytometry data.
- Published in:
- Cytometry. Part B, 2024, v. 106, n. 4, p. 282, doi. 10.1002/cyto.b.22177
- By:
- Publication type:
- Article
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis.
- Published in:
- Cytometry. Part B, 2024, v. 106, n. 4, p. 272, doi. 10.1002/cyto.b.22173
- By:
- Publication type:
- Article
MAGIC‐DR: An interpretable machine‐learning guided approach for acute myeloid leukemia measurable residual disease analysis.
- Published in:
- Cytometry. Part B, 2024, v. 106, n. 4, p. 239, doi. 10.1002/cyto.b.22168
- By:
- Publication type:
- Article
Translating the regulatory landscape of medical devices to create fit‐for‐purpose artificial intelligence (AI) cytometry solutions.
- Published in:
- Cytometry. Part B, 2024, v. 106, n. 4, p. 294, doi. 10.1002/cyto.b.22167
- By:
- Publication type:
- Article
Recommendations for using artificial intelligence in clinical flow cytometry.
- Published in:
- Cytometry. Part B, 2024, v. 106, n. 4, p. 228, doi. 10.1002/cyto.b.22166
- By:
- Publication type:
- Article
Minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukemia by semi‐automated identification of normal hematopoietic cells: A EuroFlow study.
- Published in:
- Cytometry. Part B, 2024, v. 106, n. 4, p. 252, doi. 10.1002/cyto.b.22143
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cytometry. Part B, 2024, v. 106, n. 4, p. 217, doi. 10.1002/cyto.b.22130
- Publication type:
- Article
Automation in flow cytometry: Guidelines and review of systems.
- Published in:
- Cytometry. Part B, 2024, v. 106, n. 4, p. 308, doi. 10.1002/cyto.b.22125
- By:
- Publication type:
- Article
Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence‐assisted workflow.
- Published in:
- Cytometry. Part B, 2024, v. 106, n. 4, p. 264, doi. 10.1002/cyto.b.22116
- By:
- Publication type:
- Article